RISING PHARMACEUTICALS: Drug Recall

Recall #D-0005-2022 · 09/02/2021

Class II: Risk

Recall Details

Recall Number: D-0005-2022
Classification: Class II
Product Type: Drug
Recalling Firm: RISING PHARMACEUTICALS
Status: Ongoing
Date Initiated: 09/02/2021
Location: East Brunswick, NJ, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1,344 bottles

Reason for Recall

Labeling: Incorrect Instructions

Product Description

Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01

Distribution Pattern

to be entered

Other Recalls by RISING PHARMACEUTICALS

Class II: Risk 02/15/2023

Failed Impurities/Degradation Specifications
Class II: Risk 02/07/2022

Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.

View all recalls by RISING PHARMACEUTICALS →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.